S12 E01: The 2026 pharma forecast: Opportunities and threats

As 2026 gets underway, healthcare and life sciences face a year of both promise and pressure, with investment, innovation and equity all in sharp focus. In Part 1 of this year's pharma forecast, four leaders explore where real opportunity lies, from health investment to personalisation and women's health, alongside the key threats that could slow progress. Speaker bios Dheepa Chari Vice President and Head of Global Scientific Communications, GSK Dheepa leads strategy and execution across oncology, vaccines, specialty care and general medicine, driving innovation in how scientific narratives are delivered. Emma Charles Senior Vice President of European Markets, BMS Emma oversees BMS operations across 19 countries, bringing extensive global leadership experience spanning Europe, Asia, Latin America and the Middle East. Mary Stutts CEO, Healthcare Businesswomen's Association Mary leads a global organisation advancing the impact of women in healthcare, and is a prominent advocate for inclusive leadership, representative workforces and health equity.

You can listen to S12 E01: The 2026 pharma forecast: Opportunities and threats online on Radio and Podcast. Open the player on this page to stream the available audio.

S12 E01: The 2026 pharma forecast: Opportunities and threats is an episode from The GOLD Podcast: Weekly Pharma Insights by Alice Watson.

This episode is 06:59 long.

This episode was published on Feb 17, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from The GOLD Podcast: Weekly Pharma Insights when more episodes are available from the podcast feed.